The Federal Housing Finance Agency ("FHFA") issued an Advance Notice of Proposed Rulemaking ("ANPR") in which the FHFA stated that it is conducting a review of its regulations to identify provisions that need to be updated to ensure that FHFA regulations are consistent with the statutory requirement that there be a nexus between membership in Federal Home Loan Banks ("FHLBs") and the housing and community development mission of the FHLBs.

The recently enacted America Invents Act ("AIA") is the most far reaching reform to the patent laws in the United States since 1952.

Impact fees, as the name suggests, are intended to help pay municipal costs that arise as an impact of development. The precise relationship between impact fees and those costs, however, has long been debated. In California, the appellate court recently addressed this issue in the case "Homebuilders Association of Tulare/Kings Counties, Inc. v. City of Lemoore", 2010 Cal. App. LEXIS 859 (Cal. Ct. App. 2010).

The Internal Revenue Service ("IRS") recently released revised Forms 8038, 8038-G, 8038-TC and 8038-CP. Issuers are required to complete and file the revised Form 8038 to report the issuance of private activity bonds and the revised Form 8038-G to report the issuance of tax-exempt governmental obligations.

On December 23, 2005, the IRS issued Notice 2006-4 which provides interim guidance with respect to the application of the new rules for non-qualified deferred compensation under Section 409A to stock options granted by private companies.

Goodwin's Private Investment Funds team advised Ares Credit Secondaries funds in leading a $2.5 billion credit continuation vehicle sponsored by Arcmont Asset Management, marking the largest European credit continuation fund to date. The transaction involved acquiring a diversified portfolio of primarily first-lien senior secured loans from Arcmont's 2019 vintage Direct Lending Fund III, providing liquidity to existing limited partners while enabling continued exposure to the portfolio.

Given the current market volatility, public company earnings releases are more important than ever. We have prepared the following presentation providing an overview of the..

Goodwin has been tracking disclosures in proxy statements filed by Nasdaq-listed companies since January 1, 2022 to see if they provided the Nasdaq-prescribed board diversity matrix in their proxy statements.

The U.S. Department of Commerce's Bureau of Industry and Security (BIS) is suspending the new Affiliates Rule (read our October 3, 2025 alert to learn more about the rule) until November 9, 2026.

We are pleased to present our Year-End Tool Kit, which is intended to assist you in preparing for the upcoming annual reporting and proxy season.

To assist public companies with proxy statement voting standards disclosure we have prepared the following memo. The memo contains sample disclosures that may be useful in preparing proxy...

On June 30, 2023, the Centers for Medicare & Medicaid Services (CMS) released its updated final program guidance covering the Inflation Reduction Act's Medicare Drug Price Negotiation Program...

As rare disease week gets underway, Goodwin was proud to attend the Congressional briefing held by the National Organization for Rare Disorders (NORD), "Patient Advocacy Driving Innovation for People Living with Rare Diseases."

With 10 years of litigation since the first BPCIA complaint on NEUPOGEN (filgrastim) was filed in 2014, trends are becoming apparent that should cause all biopharma companies...

After years of litigation, the handful of ERISA fee cases that have survived dismissal at the pretrial stages are starting to wend their way to trial.

Goodwin has created Model Form Bridge Financing Documents to facilitate providing urgent capital to UK-based portfolio companies to enable them to make payroll and satisfy...

Goodwin has created Model Form Bridge Financing Documents to facilitate providing urgent capital to US-based portfolio companies to enable them to make payroll and satisfy other immediate obligations.

Incyte has entered into a definitive agreement to acquire Vega Therapeutics for $1.25 billion upfront, with potential milestone payments reaching up to $2.0 billion total.

Companies are required to make information filings with the IRS in early 2011 to report exercises of incentive stock options ("ISOs") and transfers of stock purchased pursuant to employee stock purchase plans ("ESPPs") occurring in 2010.

Quarterly earnings releases are one of the most important disclosure documents that companies publish.